Study title:
Multicenter, double-blind, double dummy, randomizedparallel group study to evaluate the safety of 0.030 mg ethinylestradiol / 2 mg dienogest for 6 treatment cycles in female patients with papulopustular acne in comparison to 0.035 mg ethinylestradiol / 2 mg cyproterone acetate and placeboTI (Efficacy of cyproheptadine in the therapy of essential headache in the developmental age).
TT L'efficacia della ciproeptadina nella terapia delle cefalee essenziali in eta evolutiva.
SO Minerva pediatrica, {Minerva-Pediatr}, 30 Apr 1984, vol. 36, no. 8, p. 431-7, ISSN: 0026-4946.
AU Rosano-Burgio-F, Fazzi-E, Paglino-S, Lanzi-G. YR 1984.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases [C10]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|